Edit Szabó

532 total citations
32 papers, 396 citations indexed

About

Edit Szabó is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Edit Szabó has authored 32 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Edit Szabó's work include Drug Transport and Resistance Mechanisms (6 papers), Erythrocyte Function and Pathophysiology (5 papers) and Plant-Microbe Interactions and Immunity (3 papers). Edit Szabó is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Erythrocyte Function and Pathophysiology (5 papers) and Plant-Microbe Interactions and Immunity (3 papers). Edit Szabó collaborates with scholars based in Hungary, Japan and Austria. Edit Szabó's co-authors include György Várady, Balázs Sarkadi, Á. Németh, Judit Cserepes, Gÿorgý Kéri, Lóránt Lakatos, Ágnes Telbisz, Éva Bakos, Csilla Özvegy‐Laczka and Tamás Hegedűs and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Edit Szabó

30 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edit Szabó Hungary 13 159 109 57 53 52 32 396
Diane Nguyen United States 14 266 1.7× 96 0.9× 31 0.5× 27 0.5× 32 0.6× 44 565
Vidya P. Kumar United States 17 269 1.7× 56 0.5× 64 1.1× 49 0.9× 18 0.3× 47 571
Nivedita Bhardwaj India 11 153 1.0× 78 0.7× 30 0.5× 26 0.5× 37 0.7× 37 483
Lydia Aschauer Austria 13 321 2.0× 118 1.1× 37 0.6× 19 0.4× 33 0.6× 17 568
Hisayo Fukushima Japan 12 218 1.4× 64 0.6× 29 0.5× 27 0.5× 47 0.9× 22 434
Yasemin Başbınar Türkiye 11 133 0.8× 82 0.8× 49 0.9× 43 0.8× 11 0.2× 47 367
Xinmin Xu China 9 152 1.0× 68 0.6× 29 0.5× 30 0.6× 19 0.4× 17 439
Yih-Shou Hsieh Taiwan 15 349 2.2× 109 1.0× 33 0.6× 34 0.6× 34 0.7× 19 613
Jagannath Pal United States 10 282 1.8× 66 0.6× 17 0.3× 34 0.6× 29 0.6× 24 404
Maud Heuillet France 9 309 1.9× 62 0.6× 30 0.5× 36 0.7× 33 0.6× 11 429

Countries citing papers authored by Edit Szabó

Since Specialization
Citations

This map shows the geographic impact of Edit Szabó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Szabó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Szabó more than expected).

Fields of papers citing papers by Edit Szabó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edit Szabó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Szabó. The network helps show where Edit Szabó may publish in the future.

Co-authorship network of co-authors of Edit Szabó

This figure shows the co-authorship network connecting the top 25 collaborators of Edit Szabó. A scholar is included among the top collaborators of Edit Szabó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edit Szabó. Edit Szabó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rácz, Gergely, Éva Oláh, Máté Tóth, et al.. (2025). Identification of new reference genes with stable expression patterns for cell cycle experiments in human leukemia cell lines. Scientific Reports. 15(1). 1052–1052. 1 indexed citations
2.
Szabó, Edit, Balázs Bohár, Botond Literáti-Nagy, et al.. (2025). Genetic Variants of the Human Thiamine Transporter (SLC19A3, THTR2)—Potential Relevance in Metabolic Diseases. International Journal of Molecular Sciences. 26(7). 2972–2972.
3.
Szabó, Edit, György Várady, Judit Moldvay, et al.. (2025). Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity. PLoS ONE. 20(1). e0316396–e0316396.
4.
Erdei, Zsuzsa, Edit Szabó, György Várady, et al.. (2024). Mesenchymal Stem Cells Increase Drug Tolerance of A431 Cells Only in 3D Spheroids, Not in 2D Co-Cultures. International Journal of Molecular Sciences. 25(8). 4515–4515. 1 indexed citations
6.
Szabó, Edit, et al.. (2022). Selective Fluorescent Probes for High-Throughput Functional Diagnostics of the Human Multidrug Transporter P-Glycoprotein (ABCB1). International Journal of Molecular Sciences. 23(18). 10599–10599. 1 indexed citations
7.
Kucsma, Nóra, Balázs Bohár, Botond Literáti-Nagy, et al.. (2022). Genetic Modulation of the GLUT1 Transporter Expression—Potential Relevance in Complex Diseases. Biology. 11(11). 1669–1669. 2 indexed citations
8.
Szabó, Edit, László Korányi, Botond Literáti-Nagy, et al.. (2021). Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients. Scientific Reports. 11(1). 2765–2765. 17 indexed citations
9.
Szabó, Edit, László Korányi, Botond Literáti-Nagy, et al.. (2021). Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes. PLoS ONE. 16(12). e0260957–e0260957. 6 indexed citations
10.
Brózik, Anna, Zsolt Matula, Adrienn Borsy, et al.. (2020). Precision-engineered reporter cell lines reveal ABCG2 regulation in live lung cancer cells. Biochemical Pharmacology. 175. 113865–113865. 15 indexed citations
11.
Szabó, Edit, György Várady, Gyula Poór, et al.. (2018). Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression. Scientific Reports. 8(1). 7487–7487. 19 indexed citations
12.
Varga, Gergely, Gábor Mikala, Edit Szabó, et al.. (2017). Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 17(11). 734–742. 8 indexed citations
13.
Várady, György, Rita Padányi, Edit Szabó, et al.. (2017). Decreased calcium pump expression in human erythrocytes is connected to a minor haplotype in the ATP2B4 gene. Cell Calcium. 65. 73–79. 22 indexed citations
14.
Szabó, Edit, J. Molnár, L. Kocsis, et al.. (2016). FIRST DESCRIPTION OF GRAPEVINE SYRAH VIRUS 1 IN VINEYARDS OF HUNGARY. Journal of Plant Pathology. 97(1). 74. 4 indexed citations
15.
Hegedűs, Tamás, György Várady, Edit Szabó, et al.. (2015). Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database. 2015(0). bav056–bav056. 24 indexed citations
16.
Várady, György, Judit Cserepes, Á. Németh, Edit Szabó, & Balázs Sarkadi. (2013). Cell Surface Membrane Proteins as Personalized Biomarkers: Where we Stand and Where we are Headed. Biomarkers in Medicine. 7(5). 803–819. 41 indexed citations
17.
18.
Tsuda, Yuko, Shoji Fukushima, Toshio Yokoi, et al.. (2008). New cyclic somatostatin analogues containing a pyrazinone ring: Importance of Tyr for antiproliferative activity. Bioorganic & Medicinal Chemistry Letters. 18(23). 6199–6201. 6 indexed citations
19.
Schwab, Richárd, István Peták, Edit Szabó, et al.. (2005). [Epidermal growth factor receptor (EGFR): therapeutic target in the treatment of lung adenocarcinoma].. PubMed. 146(46). 2335–42. 2 indexed citations
20.
Jakab, Simona, et al.. (1976). An assay for selecting high risk population for gastric cancer by studying environmental factors.. PubMed. 23(3). 333–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026